ArticleFoot & ankle orthopaedics2026
Return to Sport and Functional Outcomes After Minimally Invasive Zadek Osteotomy for Insertional Achilles Tendinopathy in Young Athletes: A Retrospective Case Series.
Article in Foot & ankle orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Insertional Achilles tendinopathy (IAT) is a common cause of posterior heel pain in active individuals and athletes. Traditional open surgical techniques are effective but associated with notable morbidity and prolonged rehabilitation. Minimally invasive Zadek osteotomy (MIS Zadek) has emerged as a tendon-preserving alternative aimed at reducing soft tissue disruption and facilitating early recovery. This study evaluated clinical and functional outcomes of MIS Zadek in young, athletic patients with IAT. Methods: This retrospective single-centre case series included patients younger than 55 years who underwent MIS Zadek for symptomatic IAT between 2022 and 2024, with a minimum follow-up of 18 months. All patients were physically active before symptom onset. Procedures were performed according to the technique described by Kaplan et al. Primary outcomes included return-to-sport time, Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF), and PROMIS Pain Interference (PI). Secondary outcomes included visual analogue scale (VAS) pain scores, radiographic union, and complications. PROMIS outcomes were evaluated against established minimal clinically important difference thresholds. Results: Fifteen athletic patients (mean age, 37.2 ± 9.1 years; 10 males, 5 females) with no relevant comorbidities were included with a minimum 18-month follow-up. All patients returned to their preinjury level of sport at a mean of 4.2 ± 1.1 months. Radiographic union was achieved in all cases at a mean of 10.2 ± 2.1 weeks. PROMIS Physical Function improved from 39.6 ± 5.8 preoperatively to 52.4 ± 6.1 at 3 months and 59.1 ± 5.0 at final follow-up ( Conclusion: MIS Zadek was associated with meaningful pain relief, functional improvement, and return to sport in athletic patients with IAT in this cohort. These findings suggest that it may represent a viable tendon-preserving surgical option. Prospective comparative studies are needed to further evaluate its role relative to alternative treatments. Level of Evidence: Level IV, therapeutic case series.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.